Investigating the Use of Autologous Stem Cell Therapy in the Treatment of Androgenetic Alopecia

Autologous stem cell therapy shows promise in treating Androgenetic Alopecia (AGA), which affects 80% of the Caucasian population and significantly impacts quality of life. The study highlights the use of Rigenera® to collect and separate stem cells from the bulge region, resulting in a 29% ± 5% increase in hair density over 6 months. Other sources of multipotent stem cells, such as adipose tissue, bone marrow, and umbilical cord blood, may also be effective for hair regeneration. This approach could offer advantages over current treatments, including fewer biopsies, shorter treatment durations, and no limitations on donor follicles. Further research is needed to confirm these findings and improve therapeutic outcomes for AGA.